SNTI — Senti Biosciences, Cashflow Statement
0.000.00%
Last trade - 00:00- $27.19m
- $10.77m
- $0.02m
Annual cashflow statement for Senti Biosciences,, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -55.3 | -58.2 | -71.1 | -52.8 | -61.4 |
| Depreciation | |||||
| Non-Cash Items | 19.3 | 8.01 | 10.4 | 3.51 | 10.8 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.615 | 13.9 | 4.67 | 4.04 | 3.56 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -34.6 | -34.9 | -52.4 | -41.4 | -43.4 |
| Capital Expenditures | -5.54 | -41.4 | -12 | -0.026 | -0.196 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | -40.6 | 42.1 | 0.06 | 0.012 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -5.54 | -82 | 30.1 | 0.034 | -0.184 |
| Financing Cash Flow Items | -0.065 | 117 | 0 | 4.67 | -2.47 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 68.4 | 119 | 0.779 | 53.7 | 11.8 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 28.3 | 1.7 | -21.5 | 12.4 | -31.9 |